Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM) (OBPM_ABPM2020)

January 23, 2023 updated by: Cyril Pellaton
This study aims to assess the performances of optical blood pressure monitoring device, Aktiia.product in the context of cardiac rehabilitation program.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Neuchâtel, Switzerland, 2000
        • Réseau Hospitalier Neuchâtelois

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult subjects (aged between 21 and 65)
  • Subjects fluent in written and spoken French
  • Subjects enrolled in a 12-weeks cardiac rehabilitation program
  • Subjects agreeing to participate
  • Subjects that have signed the informed consent form

Exclusion Criteria:

  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with severe heart failure (LVEF<35%)
  • Subjects with severe renal dysfunctions (eGFR < 30mL/min/1.73 m2)
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with trembling and shivering
  • Subjects with interarm systolic difference > 15 mmHg
  • Subjects with interarm diastolic difference > 10 mmHg
  • Subjects with arm paralysis
  • Women in known pregnancy
  • Subjects with an arteriovenous fistula
  • Subjects with arm amputations
  • Subjects with the upper arm circumference > 64 cm
  • Subjects with the wrist circumference > 22 cm
  • Subjects with the exfoliative skin diseases
  • Subjects with lymphoedema

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: single arm
single arm study
The participants wear Aktiia.bracelet for the duration of the cardiac rehabilitation program. The device is initialized once per week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean absolute error for blood pressure
Time Frame: up to 24 hours
The mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product for systolic (SYS) and diastolic (DIA) blood pressure in mmHg
up to 24 hours
Mean error for blood pressure
Time Frame: up to 24 hours
The mean error between the Reference and Aktiia.product for SYS and DIA in mmHg
up to 24 hours
Standard deviation of the error for blood pressure
Time Frame: up to 24 hours
The standard deviation of the error between Reference and Aktiia.product for SYS and DIA in mmHg
up to 24 hours
Mean absolute error for heart rate
Time Frame: up to 24 hours
The mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product for heart rate in bpm
up to 24 hours
Mean error for heart rate
Time Frame: up to 24 hours
The mean error between the Reference and Aktiia.product for heart rate in bpm
up to 24 hours
Standard deviation of the error for heart rate
Time Frame: up to 24 hours
The standard deviation of the error between Reference and Aktiia.product for heart rate in bpm
up to 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the impact of ABPM induced stress on BP readings using inferential statistics.
Time Frame: 1 week
Aktiia values acquired during the first day (with ABPM) will be compared to values acquired during other days of the week and a t-test will be performed. The analysis will be repeated for night values.
1 week
Evaluation of patient's satisfaction for the two devices through a survey with multiple questions
Time Frame: up to 24 hours
10-points likert scale survey, an agree-disagree scale with minimum 0 and maximum 10. Minimum value means strong disagreement, maximum value means strong agreement.
up to 24 hours
Assessment of the calibration stability of Aktiia OBPM algorithms
Time Frame: 12 weeks
Use different calibration points going from 1 to 12 weeks
12 weeks
Assessment of systolic and diastolic blood pressure control during a 12 weeks cardiac rehabilitation program
Time Frame: 12 weeks
comparison of blood pressure determinations taken at the beginning and at the end of the program in ambulatory settings
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 6, 2020

Primary Completion (Actual)

December 23, 2022

Study Completion (Actual)

December 23, 2022

Study Registration Dates

First Submitted

August 26, 2020

First Submitted That Met QC Criteria

September 11, 2020

First Posted (Actual)

September 16, 2020

Study Record Updates

Last Update Posted (Estimate)

January 25, 2023

Last Update Submitted That Met QC Criteria

January 23, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OBPM_ABPM2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Aktiia.product

Subscribe